Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
07.04.26
/
50%
€112.90
Target price
07.04.27
€173.46
Performance (%)
11.78%
Price
12:51
€126.20
Summary
This prediction is currently active. The prediction currently has a performance of 11.78%. This prediction currently runs until 07.04.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 13.485% | 13.485% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Canaccord Genuity Group Inc. from $164.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€89.90
30.03.23
30.03.23
€120.95
30.03.24
30.03.24
47.22%
01.04.24
01.04.24
